Physician profile
Ankit A Shah
NPI 1962426056
$6,560.50
in general payments reported to CMS, 2019-2025
40 companies · $938 in 2025
The $938 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,440 · 2020: $358 · 2021: $541 · 2022: $713 · 2023: $1,071 · 2024: $1,499 · 2025: $938.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,508.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,508.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $1,248.13 | 2019-2025 | Impella |
| Novartis Pharmaceuticals Corporation | $767.62 | 2019-2025 | |
| Abbott Laboratories | $610.41 | 2019-2025 | Mitraclip, Cardiomems |
| Edwards Lifesciences Corporation | $308.38 | 2019-2023 | |
| Amgen INC. | $301.38 | 2019-2025 | Repatha, Repatha |
| Merck Sharp & Dohme LLC | $271.60 | 2021-2024 | Verquvo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $269.62 | 2019-2025 | Jardiance |
| Shockwave Medical, INC | $262.80 | 2021-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Boston Scientific Corporation | $232.45 | 2019-2024 | Watchman Flx |
| E.R. Squibb & Sons, L.L.C. | $218.72 | 2019-2023 | Camzyos |
| Pfizer INC. | $199.67 | 2019-2025 | |
| Siemens Medical Solutions USA, INC. | $195.22 | 2019 | |
| Janssen Pharmaceuticals, INC | $193.45 | 2019-2024 | Xarelto |
| Trisalus Life Sciences, INC. | $171.30 | 2024-2025 | Trinav Infusion System |
| Medtronic, INC. | $158.42 | 2021-2025 | Symplicity G3 |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ankit Shah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.